The effects of cofactor and species differences on the in vitro metabolism of propiophenone and phenylacetone

1981 ◽  
Vol 59 (2) ◽  
pp. 195-201 ◽  
Author(s):  
R. T. Coutts ◽  
D. R. Prelusky ◽  
G. R. Jones

In vitro metabolism of the aromatic ketone propiophenone and its nonaromatic isomer phenylacetone was studied using fortified 12 000 × g supernatants of liver homogenates from rat and rabbit. Reduction to the corresponding alcohols was the major metabolic route observed, although aliphatic C-hydroxylation and alcohol dehydrogenation also occurred. Marked differences were observed in the amounts of carbonyl reduction of the substrates, which was dependant on the species as well as the cofactor employed. Using rat liver preparation, phenylacetone was reduced to 1-phenyl-2-propanol much more efficiently with an NADH-fortified system than when NADPH was used whereas in rabbit, extensive reduction occurred in the presence of either cofactor. Reduction of propiophenone to 1-phenyl-1-propanol by rat liver preparation was slightly greater in the presence of NADH than with NADPH; the converse was observed in rabbit.Aliphatic hydroxylation of propiophenone to 2-hydroxy-1-phenyl-1-propamine was also a significant metabolic pathway in both species, with NADPH being the more efficient cofactor, but C-1 hydroxylation of phenylacetone to 1-hydroxy-1-phenyl-2-propanone occurred only to a minor extent. Small amounts of 1-phenyl-1,2-propanedione, as well as both erythro and threo isomers of 1-phenyl-1,2-propanediol, were also identified as metabolites in both species. Similar metabolic studies were carried out on the alcohols 1-phenyl-1-propanol and 1-phenyl-2-propanol and again the nature and quantities of metabolites isolated showed both species and cofactor dependancies.

1969 ◽  
Vol 111 (2) ◽  
pp. 167-172 ◽  
Author(s):  
J W Bridges ◽  
M. R. Kibby ◽  
S R Walker ◽  
R T Williams

1. A comparative study was made in man, rhesus monkey, rat and rabbit of the urinary excretion of 2-, 4- and 5-methoxy- and 2,4-, 2,5- and 4,5-dimethoxy-6-sulphanilamidopyrimidines given orally. 2. In the rabbit, 70–80% of the dose of each drug was excreted in 2 days, mainly as N4-acetyl derivatives, except 2,5-dimethoxy-6-sulphanilamidopyrimidine, which was mainly excreted unchanged. 3. In the rat, 50–70% of the dose of each drug was excreted in 2 days, except the 2-methoxy and 2,4-dimethoxy compounds, whose excretion was about 30%. The N4-acetyl derivatives accounted for 20–70% of the drugs excreted, except the 2,5-dimethoxy derivative, which was excreted unchanged. 4. In the rhesus monkey, some 40–60% of the dose of the 2-methoxy, 2,4-dimethoxy and 2,5-dimethoxy compounds was excreted in 2 days, but the 4-methoxy, 5-methoxy and 4,5-dimethoxy compounds were excreted at less than half this rate. The 4-methoxy, 5-methoxy and 4,5-dimethoxy compounds were highly acetylated (80–90%) whereas the 2-methoxy compound was poorly acetylated (17%) and the 2,5-dimethoxy compound hardly at all. The major metabolite of the 2,4-dimethoxy compound in the monkey was the N1-glucuronide. 5. In man, 30% of the dose of the 4-methoxy and 2,4-dimethoxy compounds was excreted in 24 hr., whereas the 4,5-dimethoxy compound (Fanasil) was very slowly excreted (12% in 2 days). The 4-methoxy compound was well acetylated (65%), but the 2,4- and 4,5-dimethoxy compounds were not (20–30%). The main metabolite of the 2,4-dimethoxy compound in man was the N1-glucuronide. 6. N1-Glucuronide formation occurred extensively only with the 2,4-dimethoxy compound and only in man and the rhesus monkey. It did not occur in the rabbit and only to a minor extent in the rat. 7. The 2,5-dimethoxy compound was not significantly acetylated in vivo in the rabbit, rat or monkey, but acetylation occurred in vitro in rabbit or monkey liver homogenates. 8. These findings are discussed.


1972 ◽  
Vol 21 (2) ◽  
pp. 275-285 ◽  
Author(s):  
Julie L. Eiseman ◽  
Perry J. Gehring ◽  
James E. Gibson

1977 ◽  
Vol 97 (3) ◽  
pp. 231-236
Author(s):  
YUZURU YAMAMOTO ◽  
KEIICHI NITTA ◽  
TOSHIAKI FUJIHASHI ◽  
IKUO UESAKA ◽  
KAZUNORI NISHIDE

Life Sciences ◽  
1986 ◽  
Vol 38 (24) ◽  
pp. 2231-2238 ◽  
Author(s):  
Shinya Kobayshi ◽  
Yan Gao ◽  
Richard L. Ong ◽  
Constance S. Pittman

Fitoterapia ◽  
2011 ◽  
Vol 82 (8) ◽  
pp. 1222-1230 ◽  
Author(s):  
Wei Zhou ◽  
Liu-qing Di ◽  
Jin-jun Shan ◽  
Xiao-lin Bi ◽  
Le-tian Chen ◽  
...  

1977 ◽  
Vol 26 (11) ◽  
pp. 1043-1049 ◽  
Author(s):  
Ronald T. Coutts ◽  
Susan H. Kovach
Keyword(s):  

Author(s):  
Andrew Machon ◽  
Michael J. North ◽  
Nicholas C. Price ◽  
David E. Wells

Sign in / Sign up

Export Citation Format

Share Document